$16.60
$0.00 (0.00%)
End-of-day quote: 05/24/2024
NYSE:TEVA
Teva Pharmaceutical Industries Annual Report
Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
$15.85B | $14.93B | $15.88B | $16.66B | $16.89B | $18.27B | $21.85B | $21.90B | $19.65B | $20.27B | $20.31B | $20.32B | $18.31B | $16.12B | $13.90B | $11.09B | $9.41B | $8.41B | $5.25B | $4.80B | |
GM % | Gross Margin % |
|
48.25% | 46.72% | 47.83% | 46.38% | 44.63% | 45.41% | 48.89% | 54.95% | 57.79% | 54.54% | 52.75% | 52.74% | 53.88% | 56.89% | 55.18% | 53.88% | 51.84% | 50.65% | 47.24% | 46.95% | |
OM | Operating Margin |
|
20.07% | 17.84% | 19.39% | 18.34% | 16.08% | 16.20% | 18.21% | 22.47% | 25.61% | 22.03% | 19.54% | 21.04% | 23.82% | 27.22% | 24.23% | 24.14% | 25.46% | 26.07% | 24.99% | 25.40% | |
EPS | Earnings Per Share |
|
$0.00 | $2.56 | $2.52 | $2.58 | $2.57 | $2.40 | $2.92 | $4.01 | $5.14 | $5.42 | $5.07 | $5.01 | $5.35 | $4.97 | $4.08 | $3.37 | $2.86 | $2.38 | $2.30 | $1.59 | $1.42 |
Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.51 | $1.36 | $1.36 | $1.36 | $1.31 | $1.08 | $0.95 | $0.78 | $0.64 | $0.50 | $0.35 | $0.31 | $0.34 | $0.20 | |
PR % | Payout Ratio % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 12.72% | 26.46% | 25.09% | 26.82% | 26.15% | 20.19% | 19.11% | 19.12% | 18.99% | 17.48% | 14.71% | 13.48% | 21.38% | 14.08% | |
Sha. | Shares |
|
1121.09m | 1110.9m | 1103.33m | 1096.51m | 1092.19m | 1089.39m | 1,017m | 1,015m | 908m | 852m | 848m | 857m | 883m | 898m | 885m | 851m | 768m | 758m | 619m | 611.4m | |
OCF | Operating Cash Flow |
|
$1.37B | $1.59B | $798.00M | $1.22B | $748.00M | $2.45B | $2.23B | $3.89B | $5.54B | $5.13B | $3.24B | $4.57B | $4.13B | $4.14B | $3.37B | $3.23B | $1.81B | $2.06B | $1.37B | $1.25B | |
FCF | Free Cash Flow |
|
$2.39B | $1.04B | $236.00M | $638.00M | $2.05B | $3.68B | $2.70B | $4.32B | $4.77B | $4.20B | $2.21B | $2.61B | $3.08B | $3.43B | $2.65B | $2.55B | $1.27B | $1.67B | $1.06B | $935.00M | |
FCFS | Free Cash Flow Per Share |
|
$0.75 | $0.94 | $0.21 | $0.58 | $0.16 | $1.75 | $1.07 | $2.86 | $5.58 | $4.92 | $2.60 | $3.98 | $3.46 | $3.82 | $3.04 | $3.27 | $1.65 | $2.21 | $1.72 | $1.53 |